These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

695 related items for PubMed ID: 18936645

  • 21. Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: a 6-year survey and cost-effectiveness analysis.
    Testoni PA, Mariani A, Masci E, Curioni S.
    Dig Liver Dis; 2006 Aug; 38(8):588-95. PubMed ID: 16731060
    [Abstract] [Full Text] [Related]

  • 22. Pancreatic duct stent placement prevents post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction but normal manometry results.
    Saad AM, Fogel EL, McHenry L, Watkins JL, Sherman S, Lazzell-Pannell L, Lehman GA.
    Gastrointest Endosc; 2008 Feb; 67(2):255-61. PubMed ID: 18028920
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Use of corticosteriods in the prevention of post-ERCP pancreatitis: results of a controlled prospective study.
    De Palma GD, Catanzano C.
    Am J Gastroenterol; 1999 Apr; 94(4):982-5. PubMed ID: 10201469
    [Abstract] [Full Text] [Related]

  • 26. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-associated pancreatitis? A randomized, prospective study.
    Cha SW, Leung WD, Lehman GA, Watkins JL, McHenry L, Fogel EL, Sherman S.
    Gastrointest Endosc; 2013 Feb; 77(2):209-16. PubMed ID: 23084272
    [Abstract] [Full Text] [Related]

  • 27. Early endoscopic retrograde cholangiopancreatography in predicted severe acute biliary pancreatitis: a prospective multicenter study.
    van Santvoort HC, Besselink MG, de Vries AC, Boermeester MA, Fischer K, Bollen TL, Cirkel GA, Schaapherder AF, Nieuwenhuijs VB, van Goor H, Dejong CH, van Eijck CH, Witteman BJ, Weusten BL, van Laarhoven CJ, Wahab PJ, Tan AC, Schwartz MP, van der Harst E, Cuesta MA, Siersema PD, Gooszen HG, van Erpecum KJ, Dutch Acute Pancreatitis Study Group.
    Ann Surg; 2009 Jul; 250(1):68-75. PubMed ID: 19561460
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis.
    Madácsy L, Kurucsai G, Fejes R, Székely A, Székely I.
    Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794
    [Abstract] [Full Text] [Related]

  • 30. Frequency of common factors for post endoscopic retrograde cholangiopancreatography pancreatitis.
    Haqqi SA, Mansoor-ul-Haq M, Shaikh H.
    J Coll Physicians Surg Pak; 2011 Aug; 21(8):464-7. PubMed ID: 21798131
    [Abstract] [Full Text] [Related]

  • 31. Incidence of pancreatitis in patients undergoing sphincter of Oddi manometry (SOM).
    Maldonado ME, Brady PG, Mamel JJ, Robinson B.
    Am J Gastroenterol; 1999 Feb; 94(2):387-90. PubMed ID: 10022634
    [Abstract] [Full Text] [Related]

  • 32. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years.
    Cotton PB, Garrow DA, Gallagher J, Romagnuolo J.
    Gastrointest Endosc; 2009 Jul; 70(1):80-8. PubMed ID: 19286178
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Can a single dose corticosteroid reduce the incidence of post-ERCP pancreatitis? A randomized, prospective control study.
    Kwanngern K, Tiyapattanaputi P, Wanitpukdeedecha M, Navicharern P.
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S42-5. PubMed ID: 16623000
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Guidewire cannulation reduces risk of post-ERCP pancreatitis and facilitates bile duct cannulation.
    Artifon EL, Sakai P, Cunha JE, Halwan B, Ishioka S, Kumar A.
    Am J Gastroenterol; 2007 Oct; 102(10):2147-53. PubMed ID: 17581267
    [Abstract] [Full Text] [Related]

  • 37. Why the incidence of post-ERCP pancreatitis varies considerably? Factors affecting the diagnosis and the incidence of this complication.
    Testoni PA.
    JOP; 2002 Nov; 3(6):195-201. PubMed ID: 12432186
    [Abstract] [Full Text] [Related]

  • 38. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
    Li ZS, Pan X, Zhang WJ, Gong B, Zhi FC, Guo XG, Li PM, Fan ZN, Sun WS, Shen YZ, Ma SR, Xie WF, Chen MH, Li YQ.
    Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
    [Abstract] [Full Text] [Related]

  • 39. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla.
    Xu LH, Qian JB, Gu LG, Qiu JW, Ge ZM, Lu F, Wang YM, Li YM, Lu HS.
    J Gastroenterol Hepatol; 2011 Jul; 26(7):1139-44. PubMed ID: 21392105
    [Abstract] [Full Text] [Related]

  • 40. Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial.
    Tsuchiya T, Itoi T, Sofuni A, Itokawa F, Kurihara T, Ishii K, Tsuji S, Kawai T, Moriyasu F.
    J Hepatobiliary Pancreat Surg; 2007 Jul; 14(3):302-7. PubMed ID: 17520207
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.